{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:30:10Z","timestamp":1787614210921,"version":"build-2736575974"},"reference-count":53,"publisher":"Impact Journals, LLC","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2023,7,31]]},"DOI":"10.18632\/aging.204920","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T18:39:34Z","timestamp":1689878374000},"page":"6632-6640","source":"Crossref","is-referenced-by-count":15,"title":["Towards disease-oriented dosing of rapamycin for longevity: does aging exist or only age-related diseases?"],"prefix":"10.18632","volume":"15","author":[{"given":"Mikhail V.","family":"Blagosklonny","sequence":"first","affiliation":[{"name":"Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"ra75","DOI":"10.1126\/scisignal.2000559","article-title":"mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells.","volume":"2","author":"Zheng","year":"2009","journal-title":"Sci Signal"},{"key":"2","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nature08221","article-title":"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice.","volume":"46","author":"Miller","year":"2009","journal-title":"Nature"},{"key":"3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/gerona\/glq178","article-title":"Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice.","volume":"6","author":"Sharp","year":"2011","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"4","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.2353\/ajpath.2010.091050","article-title":"Rapamycin extends maximal lifespan in cancer-prone mice.","volume":"17","author":"Blagosklonny","year":"2010","journal-title":"Am J Pathol"},{"key":"5","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.4161\/cc.10.24.18486","article-title":"Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice.","volume":"1","author":"Blagosklonny","year":"2011","journal-title":"Cell Cycle"},{"key":"6","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/acel.12194","article-title":"Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction.","volume":"1","author":"Sharp","year":"2014","journal-title":"Aging Cell"},{"key":"7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.18632\/aging.100496","article-title":"New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53-\/- mice by delaying carcinogenesis.","volume":"4","author":"Antoch","year":"2012","journal-title":"Aging (Albany NY)"},{"key":"8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.18632\/aging.100533","article-title":"Rapamycin extends life span of Rb1+\/\u2212 mice by inhibiting neuroendocrine tumors.","volume":"5","author":"Sharp","year":"2013","journal-title":"Aging (Albany NY)"},{"key":"9","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1172\/JCI67674","article-title":"Rapamycin extends murine lifespan but has limited effects on aging.","volume":"12","author":"Holtmeier","year":"2013","journal-title":"J Clin Invest"},{"key":"10","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1126\/science.1244360","article-title":"mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome.","volume":"34","author":"Ramos","year":"2013","journal-title":"Science"},{"key":"11","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/acel.12211","article-title":"Weekly administration of rapamycin improves survival and biomarkers in obese male mice on high-fat diet.","volume":"1","author":"Blagosklonny","year":"2014","journal-title":"Aging Cell"},{"key":"12","doi-asserted-by":"publisher","first-page":"e16351","DOI":"10.7554\/eLife.16351","article-title":"Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice.","volume":"5","author":"Beyer","year":"2016","journal-title":"Elife"},{"key":"13","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/gerona\/glw064","article-title":"Intermittent Administration of Rapamycin Extends the Life Span of Female C57BL\/6J Mice.","volume":"7","author":"Lamming","year":"2016","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"14","doi-asserted-by":"publisher","first-page":"e13269","DOI":"10.1111\/acel.13269","article-title":"Rapamycin-mediated mouse lifespan extension: Late-life dosage regimes with sex-specific effects.","volume":"1","author":"Richardson","year":"2020","journal-title":"Aging Cell"},{"key":"15","doi-asserted-by":"publisher","first-page":"dev177840","DOI":"10.1242\/dev.177840","article-title":"Deficient autophagy in epithelial stem cells drives aging in the freshwater cnidarian","volume":"14","author":"Galliot","year":"2020","journal-title":"Development"},{"key":"16","doi-asserted-by":"publisher","first-page":"eabo5482","DOI":"10.1126\/sciadv.abo5482","article-title":"Rapamycin treatment during development extends life span and health span of male mice and","volume":"8","author":"Gladyshev","year":"2022","journal-title":"Sci Adv"},{"key":"17","doi-asserted-by":"publisher","first-page":"e55299","DOI":"10.15252\/embr.202255299","article-title":"Transient rapamycin treatment during developmental stage extends lifespan in Mus musculus and Drosophila melanogaster.","volume":"2","author":"Tiberi","year":"2022","journal-title":"EMBO Rep"},{"key":"18","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s43587-022-00278-w","article-title":"Long-lasting geroprotection from brief rapamycin treatment in early adulthood by persistently increased intestinal autophagy.","volume":"2","author":"Partridge","year":"2022","journal-title":"Nat Aging"},{"key":"19","doi-asserted-by":"publisher","first-page":"e13724","DOI":"10.1111\/acel.13724","article-title":"Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous mice.","volume":"2","author":"Hamilton","year":"2022","journal-title":"Aging Cell"},{"key":"20","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s11357-020-00274-1","article-title":"Effect of rapamycin on aging and age-related diseases-past and future.","volume":"4","author":"Richardson","year":"2021","journal-title":"Geroscience"},{"key":"21","doi-asserted-by":"publisher","first-page":"8140","DOI":"10.18632\/aging.204354","article-title":"Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice.","volume":"1","author":"Blagosklonny","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-023-00867-6","article-title":"The million-molecule challenge: a moonshot project to rapidly advance longevity intervention discovery.","author":"Kaeberlein","year":"2023","journal-title":"Geroscience"},{"key":"23","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.4161\/cc.5.18.3288","article-title":"Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition.","volume":"5","author":"Blagosklonny","year":"2006","journal-title":"Cell Cycle"},{"key":"24","doi-asserted-by":"publisher","first-page":"281","DOI":"10.18632\/aging.100034","article-title":"Validation of anti-aging drugs by treating age-related diseases.","volume":"1","author":"Blagosklonny","year":"2009","journal-title":"Aging (Albany NY)"},{"key":"25","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.ajpath.2012.06.024","article-title":"Prospective treatment of age-related diseases by slowing down aging.","volume":"18","author":"Blagosklonny","year":"2012","journal-title":"Am J Pathol"},{"key":"26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.18632\/oncoscience.545","article-title":"The hyperfunction theory of aging: three common misconceptions.","volume":"8","author":"Blagosklonny","year":"2021","journal-title":"Oncoscience"},{"key":"27","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.18632\/aging.204082","article-title":"Hallmarks of cancer and hallmarks of aging.","volume":"1","author":"Blagosklonny","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"28","doi-asserted-by":"publisher","first-page":"298","DOI":"10.18632\/aging.204499","article-title":"Are menopause, aging and prostate cancer diseases?","volume":"1","author":"Blagosklonny","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"29","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1080\/15384101.2022.2054636","article-title":"Cell senescence, rapamycin and hyperfunction theory of aging.","volume":"2","author":"Blagosklonny","year":"2022","journal-title":"Cell Cycle"},{"key":"30","doi-asserted-by":"publisher","first-page":"10004","DOI":"10.18632\/aging.103493","article-title":"From causes of aging to death from COVID-19.","volume":"1","author":"Blagosklonny","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"31","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/cpt1979255part1618","article-title":"Pirprofen and aspirin in the treatment of rheumatoid arthritis.","volume":"2","author":"Ruchte","year":"1979","journal-title":"Clin Pharmacol Ther"},{"key":"32","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1158\/1940-6207.CAPR-19-0036","article-title":"Effect of Intermittent Versus Continuous Low-Dose Aspirin on Nasal Epithelium Gene Expression in Current Smokers: A Randomized, Double-Blinded Trial.","volume":"1","author":"Liu","year":"2019","journal-title":"Cancer Prev Res (Phila)"},{"key":"33","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1158\/1940-6207.CAPR-19-0312","article-title":"Intermittent Dosing Regimens of Aspirin and Naproxen Inhibit Azoxymethane-Induced Colon Adenoma Progression to Adenocarcinoma and Invasive Carcinoma.","volume":"1","author":"Rao","year":"2019","journal-title":"Cancer Prev Res (Phila)"},{"key":"34","doi-asserted-by":"publisher","first-page":"8048","DOI":"10.18632\/aging.102355","article-title":"Rapamycin for longevity: opinion article.","volume":"1","author":"Blagosklonny","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"35","doi-asserted-by":"publisher","first-page":"44876","DOI":"10.18632\/oncotarget.10381","article-title":"Rapamycin in aging and disease: maximizing efficacy while minimizing side effects.","volume":"7","author":"Kaeberlein","year":"2016","journal-title":"Oncotarget"},{"key":"36","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1158\/1078-0432.CCR-12-0110","article-title":"Phase I studies of sirolimus alone or in combination with pharmacokinetic modulators in advanced cancer patients.","volume":"1","author":"Undevia","year":"2012","journal-title":"Clin Cancer Res"},{"key":"37","doi-asserted-by":"publisher","first-page":"e0128033","DOI":"10.1371\/journal.pone.0128033","article-title":"Acute sirolimus overdose: a multicenter case series.","volume":"1","author":"Taegtmeyer","year":"2015","journal-title":"PLoS One"},{"key":"38","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/00007691-200010000-00006","article-title":"Pharmacokinetics and safety of single oral doses of sirolimus (rapamycin) in healthy male volunteers.","volume":"2","author":"Groth","year":"2000","journal-title":"Ther Drug Monit"},{"key":"39","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1080\/15384101.2019.1644765","article-title":"The mystery of the ketogenic diet: benevolent pseudo-diabetes.","volume":"1","author":"Blagosklonny","year":"2019","journal-title":"Cell Cycle"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-023-00818-1","article-title":"Evaluation of off-label rapamycin use to promote healthspan in 333 adults.","author":"Kaeberlein","year":"2023","journal-title":"Geroscience"},{"key":"41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.exger.2017.12.026","article-title":"A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects.","volume":"10","author":"Kellogg","year":"2018","journal-title":"Exp Gerontol"},{"key":"42","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jgg.2014.06.009","article-title":"Rapamycin and ageing: when, for how long, and how much?","volume":"4","author":"Kaeberlein","year":"2014","journal-title":"J Genet Genomics"},{"key":"43","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fgene.2015.00247","article-title":"Dose-dependent effects of mTOR inhibition on weight and mitochondrial disease in mice.","volume":"6","author":"Sangesland","year":"2015","journal-title":"Front Genet"},{"key":"44","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1089\/rej.2008.0722","article-title":"Aging, stem cells, and mammalian target of rapamycin: a prospect of pharmacologic rejuvenation of aging stem cells.","volume":"1","author":"Blagosklonny","year":"2008","journal-title":"Rejuvenation Res"},{"key":"45","doi-asserted-by":"publisher","first-page":"e93691","DOI":"10.1371\/journal.pone.0093691","article-title":"Single rapamycin administration induces prolonged downward shift in defended body weight in rats.","volume":"9","author":"Blundell","year":"2014","journal-title":"PLoS One"},{"key":"46","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.18632\/oncotarget.27550","article-title":"Superior cancer preventive efficacy of low versus high dose of mTOR inhibitor in a mouse model of prostate cancer.","volume":"1","author":"Gudkov","year":"2020","journal-title":"Oncotarget"},{"key":"47","doi-asserted-by":"publisher","first-page":"110","DOI":"10.18632\/oncoscience.547","article-title":"No limit to maximal lifespan in humans: how to beat a 122-year-old record.","volume":"8","author":"Blagosklonny","year":"2021","journal-title":"Oncoscience"},{"key":"48","doi-asserted-by":"publisher","first-page":"342","DOI":"10.18632\/oncotarget.28410","article-title":"Cancer prevention with rapamycin.","volume":"1","author":"Blagosklonny","year":"2023","journal-title":"Oncotarget"},{"key":"49","doi-asserted-by":"publisher","first-page":"eaar4289","DOI":"10.1126\/scitranslmed.aar4289","article-title":"Rapamycin and Alzheimer's disease: Time for a clinical trial?","volume":"1","author":"Galvan","year":"2019","journal-title":"Sci Transl Med"},{"key":"50","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.18632\/aging.101647","article-title":"Disease or not, aging is easily treatable.","volume":"1","author":"Blagosklonny","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"51","doi-asserted-by":"publisher","first-page":"39082","DOI":"10.18632\/oncotarget.9681","article-title":"Run-on of germline apoptosis promotes gonad senescence in C. elegans.","volume":"7","author":"Gems","year":"2016","journal-title":"Oncotarget"},{"key":"52","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41514-018-0025-3","article-title":"A parthenogenetic quasi-program causes teratoma-like tumors during aging in wild-type","volume":"4","author":"Gems","year":"2018","journal-title":"NPJ Aging Mech Dis"},{"key":"53","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1089\/ars.2012.4840","article-title":"Alternative Perspectives on Aging in Caenorhabditis elegans: Reactive Oxygen Species or Hyperfunction?","volume":"1","author":"de la Guardia","year":"2013","journal-title":"Antioxid Redox Signal"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204920","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T00:49:47Z","timestamp":1691282987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":53,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023,7,31]]}},"alternative-id":["204920","37477535"],"URL":"https:\/\/doi.org\/10.18632\/aging.204920","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]}}}